Vaccine Articles | Global Biodefense

Menu

Latest stories

Counterfeit Medications: What We Know and What Needs to be Done

Nanoscale CBRN Defense

CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes

More on pathogens and preparedness

8th FIDSSA Congress – Federation of Infectious Diseases Societies of Southern Africa

by Global Biodefense November 7, 2019, 12:00 am
Why Ebola Vaccine on Trial in DRC is Raising Hopes

by Shirin Ashraf and Arthur Wickenhagen, University of Glasgow February 10, 2019, 11:21 pm
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

by Global Biodefense January 22, 2019, 3:00 am
CDC Fiscal Year 2019 Broad Agency Announcement

by Global Biodefense December 7, 2018, 9:05 am
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine

by Global Biodefense November 15, 2018, 10:57 am
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated
New Biomarkers Associated with Protection by RTS,S Malaria Vaccine

by Global Biodefense October 30, 2018, 8:00 pm
A Review of Ebola Vaccine Candidates

by Global Biodefense August 19, 2018, 3:52 pm
First Human Trial of Live, Attenuated Zika Vaccine Begins

by Global Biodefense August 16, 2018, 10:36 am
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine
Submit Your Suggestions for the NIAID Tuberculosis Strategic Framework

by Global Biodefense July 5, 2018, 11:10 am

Congratulations. You've reached the end of the internet.

Back to Top

Close

close